75 results
8-K
EX-99.1
IXHL
Incannex Healthcare Limited
30 Sep 24
Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates
4:01pm
,
Assets
Current assets:
Cash and cash equivalents
Prepaid expenses and other assets
R&D tax incentive receivable
Total current assets
Property, plant … expenses
Loss from operations
Other income, net:
R&D tax incentive
Foreign exchange expense
Interest income
Total other income, net
Loss before income
10-K
2024 FY
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
in the future. Our ability to achieve profitability depends on the successful development of our drug candidates.
We rely on R&D tax incentives to provide … resources to conduct our business operations. If the amount of R&D tax incentives decreases, our results of operations and cash resources may be materially
10-K
2024 FY
EX-4.2
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
of the Company the amount of such tax, if any, or shall have established to the reasonable satisfaction of the Company and the Warrant Agent that such tax
10-K
2024 FY
EX-10.9
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
for the benefit of Australian Participants. The purpose of this Australian Subplan is to facilitate compliance with Australian tax, securities, and other applicable … withholdings such as PAYG tax.
17. Disposal Restrictions Attached to Common Shares.
(a) All Common Shares acquired by Participants or held
8-K
EX-10.2
IXHL
Incannex Healthcare Limited
10 Sep 24
Entry into a Material Definitive Agreement
7:30am
or acquired after the date hereof, including in connection with and following the date of the Merger.
“Tax” or “Taxes” means any federal, state … research and development tax incentives for the Company’s fiscal years ended June 30, 2023 and June 30, 2024;
(xv) all information requested
8-K
1gjwscy1
10 Sep 24
Entry into a Material Definitive Agreement
7:30am
8-K
EX-10.1
r2vq8syo206q48
10 Sep 24
Entry into a Material Definitive Agreement
7:30am
S-1/A
EX-10.10
54633kxrwcid
17 Jul 24
IPO registration (amended)
8:47am
S-1/A
yrr3ir603vm
17 Jul 24
IPO registration (amended)
8:47am
S-1/A
EX-4.3
dyhh uas9tzp8
17 Jul 24
IPO registration (amended)
8:47am
S-1/A
EX-10.9
v8k wypp3n
17 Jul 24
IPO registration (amended)
8:47am
S-1
6w5evr5h5x eqa2ql
3 Jul 24
IPO registration
6:29am
10-Q
z7j5cb4r1369qx
14 Feb 24
Quarterly report
6:16am
8-K
EX-10.2
6oidqg3lpie0kmf
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-2.1
j870nj9vy51uijgdoea
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
6-K
EX-99.1
7fd8ah 4j2
26 Oct 23
Incannex Healthcare September 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
6:02am
6-K
EX-99.1
wue7m91v16m vj
1 Sep 23
Report of Foreign Private Issuer
12:00am